Silver Book Fact

A study exploring the decline in deaths attributable to cardiovascular disease in the U.S. from 1980 to 2000 suggested that approximately 47% of the decrease was due to the increased use of evidence-based medical therapies. 44% was due to changes in the risk factors of the population attributable to lifestyle and environmental changes.

Ford E, Ajani U, Croft J, Critchely J, et al. Explaining the Decrease in US Deaths from Coronary Disease, 1980-2000. N Engl J Med. 2007; 356: 2388-98. http://www.nejm.org/doi/full/10.1056/NEJMsa053935

Reference

Title
Explaining the Decrease in US Deaths from Coronary Disease, 1980-2000
Publication
N Engl J Med
Publication Date
2007
Authors
Ford E, Ajani U, Croft J, Critchely J, et al.
Pages
2388-98
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Full medication coverage is expected to increase patient compliance from 50% to 76%. Expanded coverage would cost insurers an average of $644 more per patient, but would avert an average…  
  • Without antihypertensive drug therapy, there would have been about 572,000 more hospital discharges for stroke in 2002 and 261,000 more discharges for myocardial infarction.  
  • Trends in carotid endarterectomy procedures  
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • Several prevention/early detection interventions for cardiovascular disease have cost-effectiveness ratios of $50,000-$70,000 per life saved.